Medtronic refutes Senate claims that it put spin on Infuse studies
This article was originally published in Clinica
Executive Summary
Medtronic's problems with its Infuse bone graft refuse to blow over, after a US Senate investigation concluded that the firm was "heavily involved in drafting, editing and shaping content of medical journal articles" about the product.